Thema: Reshaping
Why, Eli
loss-4890196_1920.jpg - Foto: THN
Why Eli Lilly’s Mounjaro Is Reshaping Obesity Care — and the LLY Stock Story Behind It
Eli Lilly’s GLP?1 blockbuster Mounjaro is transforming obesity and diabetes treatment in the US — and rewriting the company’s growth profile. Here’s how the drug works why it’s in such explosive ...
ad-hoc-news.de, 28.12.25 15:24 Uhr
